In response to the possible quality risks of some centrally purchased drugs, the National Medical Insurance Administration took the lead in the investigation.
2025-01-20 00:04:45
Targeted at certain drugs possible existence quality risk problem countrydesk3cryptocurrencydesktopCrypto News
In response to the possible quality risks of some centrally purchased drugs, the National Medical Insurance Administration took the lead in the investigation.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Next article：
特朗普：将指示军方启动铁穹导弹防御盾的建设。所有设备都将由美国制造。
